When was Santarus founded?

Santarus was founded in 1996 and raised its 1st funding round 7 years after it was founded.

Where is Santarus located?

Santarus is headquartered in San Diego, United States.

How many employees does Santarus have?

As of Aug 31, 2026, the latest employee count at Santarus is 81.

Is Santarus a funded company?

Santarus is a funded company, having raised a total of $***** in its 1st and only funding round, a Series D round on May 22, 2003.

When was the latest funding round of Santarus?

Santarus' latest funding was a $***** Series D round on May 22, 2003, with participation from 9 investors.

What is the annual revenue of Santarus?

Annual revenue of Santarus is between $100M and $500M as on Dec 31, 2012

Santarus - 2026 Company Profile & Funding

Santarus is an acquired company based in San Diego (United States), founded in 1996. It operates as a Specialty biopharma company marketing drugs for type II diabetes, ulcerative colitis and others.. Santarus has raised $51.4M in funding from SR One.

Company Details

Santarus, a specialty biopharmaceutical company is focused on acquiring, developing and commercializing proprietary products with a focus on gastrointestinal diseases. Its products include Uceris, approved last year for treating ulcerative colitis, as well as the stomach acid-reducing combination pill Zegerid. But Santarus also have products that work on conditions outside the gastrointestinal tract. It has two oral treatments for Type 2 diabetes, Glumetza and Cycloset, and Fenoglide, used to lower high cholesterol.

Key Metrics

Founded Year

1996

Location

San Diego, United States

Stage

Acquired

Total Funding

$51.4M in 1 round

Latest Funding Round

Series D, May 22, 2003, $*****

Investors

SR One & 12 more

Annual Revenue

$100M - $500M as on Dec 31, 2012

Employee Count

81 as on Aug 31, 2026

Exit Details

Acquired by Salix Pharmaceuticals (Nov 07, 2013)

View Santarus' full profile

Santarus is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Santarus Inc CIN: 1172480 , United States, Active	May 20, 1987	$100M - $500M (As on Dec 31, 2012)	-	-

Santarus got acquired by Salix Pharmaceuticals on Nov 07, 2013 at an acquisition amount of $*****.

Click here to take a look at Santarus's acquisition in detail

Santarus has raised a total funding of $51.4M over 1 round. Its latest funding round was a Series D round on May 22, 2003 for $*****. 9 investors participated in its latest round. Santarus has 13 institutional investors.